Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the world's leading drugmakers, missed last ...
Barry Snyder, left, chief technology officer for AI event-planning startup platform Eventio, and CEO Erin Kerner are shown at ...
The Joint Department of Biomedical Engineering, a collaboration between NC State and UNC-CH, received a $20 million ...
Agoura Hills-based biotech firm Acelyrin Inc. agreed to merge with San Francisco-based Alumis Inc. in a deal valued at $320 ...
A biotech company is attempting to persuade Kansas legislators to modify the state’s controlled substances act in advance of ...
Moderna shares fell 3% in premarket trading after the biotech company swung to a quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion, ...
UNC Charlotte received the most NIH funding in the area — $56 million since the 2015 fiscal year. The university received ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...
How Goodhart’s Law Reveals the Opportunity in Long-Term Innovation Investing, and why traditional performance metrics may be ...
Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results